CARRYVAC-HIV Trademark

Trademark Overview


On Friday, June 28, 2002, a trademark application was filed for CARRYVAC-HIV with the United States Patent and Trademark Office. The USPTO has given the CARRYVAC-HIV trademark a serial number of 78140045. The federal status of this trademark filing is ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE as of Tuesday, July 22, 2003. This trademark is owned by Tripep AB. The CARRYVAC-HIV trademark is filed in the Pharmaceutical Products category with the following description:

PHARMACEUTICAL PREPARATIONS FOR USE IN THE TREATMENT AND PREVENTION OF HUMAN IMMUNEDEFICIENCY VIRUS

General Information


Serial Number78140045
Word MarkCARRYVAC-HIV
Filing DateFriday, June 28, 2002
Status602 - ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE
Status DateTuesday, July 22, 2003
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing1000 - Typeset: Word(s) / letter(s) / number(s)
Published for Opposition DateNOT AVAILABLE

Trademark Statements


Goods and ServicesPHARMACEUTICAL PREPARATIONS FOR USE IN THE TREATMENT AND PREVENTION OF HUMAN IMMUNEDEFICIENCY VIRUS
Pseudo MarkCARRY VACCINE HUMAN IMMUNEDEFICIENCY VIRUS

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, July 9, 2002
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameTripep AB
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressHuddinge
SE

Trademark Events


Event DateEvent Description
Tuesday, July 22, 2003ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
Friday, December 6, 2002NON-FINAL ACTION E-MAILED
Friday, November 29, 2002ASSIGNED TO EXAMINER